<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR134">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zhou</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Pan</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Q</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Bai</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Peng</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Tao</surname>
    <given-names>L</given-names>
   </name>
  </person-group>
  <article-title>Glycopeptide antibiotics potently inhibit cathepsin L in the late endosome/lysosome and block the entry of Ebola virus, Middle East respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus (SARS-CoV)</article-title>
  <source>J Biol Chem</source>
  <year>2016</year>
  <volume>291</volume>
  <fpage>9218</fpage>
  <lpage>9232</lpage>
  <pub-id pub-id-type="doi">10.1074/jbc.M116.716100</pub-id>
  <?supplied-pmid 4861487?>
  <pub-id pub-id-type="pmid">26953343</pub-id>
 </element-citation>
</ref>
